Pulp Disease, Dental Clinical Trial
Official title:
Evaluation of Clinical and Radiological Success of Vital Amputation Treatment Applied in Teeth With Irreversible Pulpitis Using MTA
Total amputation therapy; is a treatment method aimed at maintaining the vitality of the
radicular pulp remaining as a result of complete removal of coronal pulp tissue. In cases
where pulp is exposed due to caries or trauma, the pulp is vital, bleeding can be controlled
during the procedure, no periapical pathology is seen and radicular pulp is healthy.
Traditionally, acute pulp pain is thought to be a symptom of irreversible pulpitis, and it is
thought that there is little chance of the pulp returning to its normal situation after
removal of the irritants. Root canal treatment has been accepted as the gold standard for the
treatment of these symptoms. In recent studies, spontaneous or severe pain before procedure
has not always indicated that pulp has no repair capacity, and deep carious lesions are not
necessarily associated with irreversible pulpal pathology. Histological studies showed that
even when caries reach the pulp or degeneration and inflammation were seen in it, there was a
healthy section still present in the pulp. Therefore, it is stated that the healthy pulp
remaining as a result of total amputation performed by removal of degenerated pulp can be
preserved. Furthermore, it is stated that for the healing potential of the remaining pulp
tissue, the original signal should be that the bleeding can be controlled after the
amputation of the infected pulp tissue.
While the most popular method in the treatment of vital pulp is CaOH, the American Academy of
Pediatric Dentistry has been reported to be more resistant to dissolution in the protocol in
recent years. MTA is a more suitable material because it is more homogeneous, and forms a
thicker dentin bridge. However, the MTA requires a long time to harden, it is difficult to
manipulate and color. In recent years, researchers have focused on creating new MTA
formulations to improve their physicochemical properties without affecting their
biocompatibility and bioactivity.
NeoMTA Plus is a new fine powder tricalcium silicate. It consists of a water-based gel and
powder mixture and the powder-gel mixing ratio may vary depending on the area of use. It is a
material similar to MTA Plus. However, in order to avoid tooth discoloration, tantalium oxide
used instead of the bismuth oxide and required calcium hydroxide used to induce the formation
of mineralized tissue.
This study was approved by the Ondokuz Mayis University Clinical Research Ethics Committee
(OMU KAEK 2018/352) All clinical treatments will be carried out by two researchers as
pediatricians for patients aged 8-18 years and endodontics specialists for patients over 18
years of age. All patients who have participated in the study will be informed by written and
verbal information. In the study, two groups will be formed according to the two age groups.
According to the results of power analysis, 95% confidence and 94.3% test power for each
group 30 cases, in total 60 cases will be taken. Patients included in the study will be
treated for lower molar and lower / upper premolar teeth. Five patients who underwent root
canal treatment from each age group will be used as a control group to evaluate the
dimensional changes of the root canal by the evaluation of their periapical radiograph.
The patient's age, gender, type of tooth, location and complaint of the patient will be
recorded prior to clinical procedures. After clinical examination including percussion test,
palpation test, vitality control, and periodontal examination, the radiographic evaluation
will be completed by taking the periapical radiograph of the relevant tooth in parallel
technique.
A local anesthetic solution containing 2% articaine hydrochloride (Ultraca from Sanofi
Aventis, Istanbul, Turkey) will be applied to the tooth which will include, followed by
isolation the tooth with rubber dam will be performed. Following the disinfection of the
isolated tooth crown with 2% chlorhexidine gluconate, the current caries lesion will be
removed under water cooling with the aid of sterile diamond drills and low-speed single-use
steel rod drills, the teeth where the infected pulp has been completely removed but the pulp
is not mechanically exposed. Indirect pulp treatment will be applied.
In case that the pulp is exposed while infected dentin is removed, the working protocol will
be applied to the teeth. Accordingly, first, remove the dentin around the exposure area and
remove the roof of the pulp chamber, then by using thick diamond drills under water cooling
the coronal pulp until the level of the canal orifices will remove. To ensure hemostasis,
sterile cotton pellets impregnated with 2.5% NaOCl will be kept 5min at the orifices of the
canal. The procedure shall be repeated for a maximum of 3 times with a bleeding control every
5 minutes. At the end of 15 minutes, root canal treatment will be applied to the teeth where
hemostasis is not provided. 2mm calcium silicate-based material (NeoMTA Plus) (Avalon Biomed
Inc., Bradenton, FL, USA) will be placed on the expansive pulp tissue in the canal opening.
In accordance with the manufacturer's instructions, NeoMTA Plus will be prepared by mixing a
scale of powder with 1 drop of gel for 30 seconds and after being transported to the cavity,
it will be lightly pressed with a damp cotton pellet and adapted to the base of the pulp
chamber. The chemically curing glass ionomer will be applied as a cement base material. The
enamel surfaces of the teeth will then be acidified for 30 seconds with 37% phosphoric acid
for selective acidification. After the cavity is washed with plenty of water and dried at the
humidity level, the binding agent (Single Bond Universal 3M / ESPE, USA) will be light-cured
by applying to the enamel and dentin surface in 2 coats according to the company
instructions. A nanoparticle composite (Filtek Ultimate, 3M / ESPE) will be applied to the
cavity with 2 mm each layer technique and will be polymerized with the same LED device
(Elipar FreeLight, 3M ESPE, Seefeld, Germany) for the 20s each layer. Following finishing and
polishing operations, it will rebond the cavity limits. After the procedure, periapical
radiograph will be taken again with parallel technique by using a film holder to ensure
standardization from all teeth. All patients will be called up for follow-up every 3 months
during the first year and then every 6 months. In the control, the relevant teeth shall be
subjected to a cold test and an electrical pulp test (on the appropriate teeth). Also; the
presence of postoperative pain, how long it will last, presence/absence of clinical symptoms,
filling quality, presence of pulp obliteration will be evaluated. In addition, periapical
radiograph will be taken with parallel technique. Assessments will be made by 2 researchers.
Cohen kappa analysis will be conducted to evaluate the consistency between the researchers.
In situations where both clinical and radiographic findings are within normal limits will be
recorded successfully. Pain, swelling, presence of sinus tract and presence of radiolucency
in the periapical region will be recorded as a failure.
Radiographs taken from the patient by parallel technique will be recorded in digital
environment and dimensional changes in root length, increase in dentin amount, the space of
the root canal will be evaluated using Image J software program.
Statistical evaluation:
Statistical analysis of the data to be obtained:
The McNemar test was used for the statistical evaluation of the success levels for the
time-dependent group. In the purpose of evaluation McNemar test , Two-Rate Z test will be
applied to determine the differences between the groups (p <0.05).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06467890 -
Knowledge of Vital Pulp Therapy in Permanent Teeth After Educational Programme: A Before and After Study
|
||
Not yet recruiting |
NCT05981352 -
Evaluation of Different Materials in Pulpotomy of Primary Molars
|
N/A | |
Recruiting |
NCT06227390 -
Clinical and Radiographic Outcomes of Partial Pulpotomy Procedure in Primary Molars Utilizing Different Capping Materials and Different Restorative Methods
|
N/A | |
Completed |
NCT06398327 -
Efficacy Of Proinflammatory Cytokines in The Primary Molar Pulpotomy
|
N/A | |
Active, not recruiting |
NCT03580135 -
Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars
|
Phase 2 | |
Recruiting |
NCT03410134 -
Assessment of Vital Pulp Therapy in Permanent Molars
|
N/A | |
Recruiting |
NCT04793477 -
Effectiveness of Rotating System and Single File Reciprocating System in Temporal Molars
|
N/A | |
Completed |
NCT04274920 -
Dentin Bridge Formation After Indirect Pulp Capping With Bioactive Glass Incorporated in Resin Composite and Its Adhesive in Comparison With Light Cured Calcium Hydroxide
|
N/A | |
Not yet recruiting |
NCT05839548 -
Articaine Efficacy and Safety for 3 Years Old Children
|
Phase 3 | |
Active, not recruiting |
NCT05912907 -
Potassium Nitrate in Polycarboxylate as a Direct Pulp Capping
|
N/A | |
Completed |
NCT05633537 -
Clinical & Radiographic Evaluation of Zinc Oxide-Ozonated Oil as a New Primary Root Canal Filling
|
N/A | |
Completed |
NCT06110494 -
A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment
|
Phase 4 | |
Completed |
NCT03542019 -
Survival of Endocrowns Made From Different Ceramics
|
N/A | |
Completed |
NCT06002646 -
Lasers as an Alternative to Formocresol and Sodium Hypochlorite Medicaments in Pulpotomy Techniques
|
Phase 4 | |
Not yet recruiting |
NCT03368391 -
: Pulpal Blood Flow With the Use of Intra-nasal Anesthetic
|
Phase 4 | |
Recruiting |
NCT06196515 -
Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04650113 -
Clinical and Radiographic Assessment of Partial and Complete Pulpotomy in Primary Molars Using MTA
|
Phase 1/Phase 2 | |
Completed |
NCT06129643 -
Post-operative Pain After Laser Root Canal Treatment of Necrotic Teeth With Apical Periodontitis
|
Phase 2 | |
Recruiting |
NCT06207253 -
The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament
|
Phase 2/Phase 3 | |
Completed |
NCT03582319 -
Clinical and Radiographic Evaluation of Biodentine Versus Formocresol
|
N/A |